Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Endocrinology | Family Medicine
 Disease Category: Endometriosis
Location: United States, ND

Trial Information

A study for patients who have moderate to severe pain associated with endometriosis

A study of an investigational medication for the treatment of endometriosis

Patient Inclusion Criteria:

  • Patients who are a premenopausal female, between 18 and 49 years of age
  • Patient has a clinical diagnosis of endometriosis

Patient Exclusion Criteria:

  • Patient cannot be pregnant or breast feeding
  • Patient is less than 6 months postpartum, post-abortion, or post-pregnancy at the time of entry into the Screening Period
  • Patient has a surgical history of: hysterectomy (with or without oophorectomy), bilateral oophorectomy, vagotomy, bowel resection or any surgical procedure (including gastric surgery) that might interfere with gastrointestinal motility, pH, or absorption
  • any major surgery (including laparotomy for endometriosis) within 6 months or any surgery (including laparoscopy for endometriosis) within 3 months prior to Screening, or is scheduled for a surgical procedure during the course of the study.

Joan Galbraith, Manager
St. Alexius Medical Center
1310 East Main Ave., Suite 203
Bismarck, ND 58501
Phone: (701) 530-6950
Fax: (701) 530-6970
Email: jgalbraith@primecare.org

View Map

Research Center Information: St. Alexius Medical Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.